N/A
N=148
Improving Communication Between Cancer Patients & Oncologists
Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02969031 ↗Enrolled (actual)
148
Serious AEs
—
Results posted
Jan 2020
Primary outcome: Primary: Provider to Patient Communication Score — 1.0423; 1.0723 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Enhanced SCOPE training (Behavioral); Standard Communication training (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Dana-Farber Cancer Institute
- Primary completion
- Aug 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Provider to Patient Communication Score |
1.0423; 1.0723 | — |
| SECONDARY Empathic Response to Patient Expressions of Negative Emotions |
0.2054; 0.1203 | — |
Summary
The overarching goal of this project is to improve communication between oncologists and their patients by ensuring that the patient's voice is heard in the medical encounter. Thus, the hope is to improve the experience for patients living with cancer. The investigators seek to accomplish this goal by providing oncologists communication skills training that includes feedback on their own audio-recorded conversations. The feedback will come from two sources: 1) Professional research assistant coders who will identify objective learning opportunities based on specific coding criteria and 2) Trained patient reviewers who will listen to the recordings and offer their own, subjective feedback at key moments in the encounters.
Eligibility Criteria
Inclusion Criteria
- All American Board of Internal Medicine (ABIM) Board certified oncologists practicing in the U. S. and enrolled in Maintenance of Certification.
- Have a study-compatible smart phone.
- Eligible patients will have metastatic cancer.
- At least 18 years of age.
- Speak and read English.
- Receive oncology care from an enrolled oncologist.
Exclusion Criteria
- Dana Farber Cancer Institute oncologists and oncologists who do not speak English to their patients.
- Patients who do not speak English.
Data sourced from ClinicalTrials.gov (NCT02969031). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.